High-level speakers such as Anja Karliczek (German Federal Minister of Education and Research), Jens Spahn (German Federal Minister of Health) and representatives of the European Commission (DG RTD & CNECT) have confirmed their participation.
Best practice sessions on research and implementation will give successful examples for translation of personalised medicine research into an added value for the patient, such as the implementation of personalised lung cancer care in clinical routine in Germany or the implementation of personalised medicine for rare diseases and cancer in Sweden. This will be done in a comprehensive approach, giving room for representatives of all relevant steps (e.g. researchers, clinicians, payers, patients) to describe their views and experiences.
Further sessions will encompass examples for policy making and impact analysis on personalised medicine research from the ICPerMed member states. High-level key note talks on different aspects of personalised medicine will broaden up the conference perspective and provide international views on personalised medicine in China and India. Speakers and lecture topics can be taken from the final programme.
In addition, the winners of the ICPerMed 'Best Practice in Personalised Medicine' Award will be announced and will present their results during a plenary session.
For those who cannot make it to the conference, a live stream of the lectures will be provided on the ICPerMed website on November 20-21.